Should Investors Buy the Post-Earnings Dip in Salesforce (CRM) Stock?

Core Viewpoint - Salesforce's stock experienced a significant drop despite favorable Q2 results, raising questions about its investment potential amid slower growth and high expectations [1][2]. Financial Performance - Q2 sales reached $10.23 billion, a 10% increase from $9.32 billion year-over-year, surpassing estimates of $10.13 billion [3]. - Q2 earnings per share (EPS) were $2.91, up 13% from $2.56 a year ago, exceeding expectations of $2.77 by 5% [3]. - Revenue from AI and data products surged 120% year-over-year, indicating strong performance in this segment [4]. Operational Highlights - Salesforce reported a non-GAAP operating margin of 34.3% and a Current Remaining Performance Obligation (CRPO) of $29.4 billion, reflecting an 11% increase [4]. - The company secured deals with major clients including Dell, Marriott, U.S. Bank, the U.S. Army, and Lululemon [5]. Future Guidance - Salesforce raised its full-year revenue guidance to between $41.1 billion and $41.3 billion, indicating approximately 8.5%-9% growth [7]. - The company expects to achieve nearly $15 billion in operating cash flow for FY26, with growth forecasted at 12%-13% [7]. Valuation Metrics - Salesforce stock is currently trading at a forward P/E ratio of 22X, below the S&P 500's 24X and the industry average of 25X [10]. - The stock is trading at a 43% discount to its 3-year median of 39X forward earnings, significantly lower than its peak of 75X during this period [10]. Investment Consideration - The company's ability to leverage AI and compete against rivals like Microsoft makes investing in Salesforce stock increasingly attractive, although there may be better buying opportunities in the future [11].